LIF and IL5 have been demonstrated to mediate antigen-specific immune tolerance through induction and modulation of regulatory T cells (37, 38), while IL6 is known to suppress CD8+ T cell–mediated clearance of B-ALL in response to chemotherapy (39). Here, LIF is linked to acute lymphoblastic leukemia.